Nachrichten zur ASTRAZENECA PLC DL-,25 Aktie

Stocks making the biggest moves midday: Peloton, Lam Research, Lowes, AstraZeneca and more

These are the stocks posting the largest moves midday.…

AstraZeneca strebt für 2030 einen Gesamtumsatz von 80 Milliarden US-Dollar und ein nachhaltiges Wachstum nach 2030 an

CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca gab heute sein ehrgeiziges Ziel bekannt, 2030 einen Gesamtumsatz von USD 80 Mrd. zu erzielen – gegenüber…

FTSE 100 dips on rates concerns, AstraZeneca outlines ambitious plans

The FTSE 100 dipped on Tuesday after investors were served an unwelcome reminder that the Federal Reserve rate cuts were…

AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters

AstraZeneca aims for $80 billion in total revenue by 2030…

AstraZeneca shares rise as pharma group unveils 2030 revenue target By Investing.com

AstraZeneca shares rise as pharma group unveils 2030 revenue target…

AstraZeneca: Der Pharma-Konzern setzt sich ehrgeizige Wachstumsziele - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

AstraZeneca targets $80 billion in total revenue by 2030 in post-Covid era

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including…

Antiandrogens Market Insights and Projections to 2030: An $8.7 Billion Landscape Dominated by Pfizer, Astellas Pharma, Roche, AstraZeneca, and Abbott Labs

Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Antiandrogens Market Report: Trends, Forecast and Competitive Analysis to 2030"…

Astra Aims to Almost Double Sales to $80 Billion by 2030

Astrazeneca CFO Aradhana Sarin discusses the companys growth plans with Guy Johnson, Kriti Gupta and Anna Edwards on Markets Today.…

Astrazeneca will Umsatz bis 2030 fast verdoppeln

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca will durch die Einführung zahlreicher neuer Medikamente in den…

AstraZeneca aims to boost revenues to $80bn by 2030

AstraZeneca PLC (LSE:AZN) aims to grow its revenue by about 75% to $80 billion by 2030, driven by the launch…

European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target By Investing.com

European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target…

FTSE 100 live: Blue-chips fall as Pennon hits water companies, AstraZeneca and Greencore climb

FTSE 100 falls 34 points to 8390 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 closes lower as IMF warns against UK tax cuts

FTSE 100 falls 7 points to 8416 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 live: Blue-chips fall as Pennon hits water firms, AstraZeneca up Greencore soars

FTSE 100 falls 37 points to 8387 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets for…

FTSE 100 live: Blue-chips set to slide on oil price drop, AstraZeneca sets new targets

7.39am: Kingfisher sales down but guidance maintained B&Q and Screwfix owner Kingfisher PLC (LSE:KGF) reported a 0.9% decline in like-for-like (LFL) sales...…

FTSE 100 live: Blue-chips fall out of bed, Pennon hits water companies, AstraZeneca rises

FTSE 100 falls 22 points to 8402 Pennon leads water companies lower AstraZeneca sets new targets for decade 8.28am: Water…

FTSE 100 live: Blue-chips fall, IMF warns against UK tax cuts, US stocks to open lower

FTSE 100 falls 29 points to 8395 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 live: Blue-chips almost flat as IMF warns against UK tax cuts

FTSE 100 falls 7 points to 8417 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets…

FTSE 100 live: Blue-chips fall out of bed, AstraZeneca a rare riser

8.07am: FTSE 100 falls out of bed The FTSE 100 has dropped 30 points to 8394 in initial trades, with all…

FTSE 100 live: Blue-chips fall as Pennon hits water firms, AstraZeneca and Greencore climb

FTSE 100 falls 37 points to 8387 Pennon hits water sector after cutting £2.4m from dividend AstraZeneca sets new targets for…

AstraZeneca to deliver $80bn revenue by 2030

21 May 2024 AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030 Launch of 20…

Ihre wichtigsten Termine: Heute im Fokus: AstraZeneca, Kingfisher, Shell, Macys & Assicurazioni Generali

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.…

AstraZeneca, Amgen release mid-stage data on Tezspire for COPD

…

[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

JPMORGAN stuft ASTRAZENECA auf Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 13000 Pence auf…

Pfizer wins cancer drug patent case against AstraZeneca

…

AstraZeneca to manufacture ADCs in Singapore

20 May 2024 AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore Operationally ready by 2029, it will be…

AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore

This new plant will be AstraZenecas (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish.…

Director/PDMR Shareholding

15 May 2024 15:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 13 May 2024, Pascal…

BenevolentAI and AstraZeneca discover novel heart failure target using AI

BenevolentAI (AMS:BAI, OTC:BAIVF) told investors it has reached an important milestone in its collaboration with AstraZeneca, helping the drug-maker add…

Sanofi, Pfizer, AstraZeneca invest a combined €1.87B to bolster operations in France

In two months, countries from around the world will send athletes to France to compete in the 2024 Summer Olympics.…

Microsoft, Amazon and AstraZeneca invest billions in France

Microsoft Corp (NASDAQ:MSFT) said it will join a string of mega-cap companies in investing billions into the French economy after…

Microsoft, Amazon and AstraZeneca invest billions in France

Microsoft Corp (NASDAQ:MSFT) said it will join a string of mega-cap companies in investing billions into the French economy after…

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

President Emmanuel Macron will kick off the annual Choose France event aimed at wooing big overseas businesses and investors on…

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France By Reuters

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France…

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion,…

Pfizer and AstraZeneca Announce New Investments of Nearly $1 Billion in France

PARIS (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of…

AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand

Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.…

AstraZeneca: Vor großem Kaufsignal - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand

AstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that initially raised…

Zulassung für Impfstoff von AstraZeneca zurückgezogen

In der Europäischen Union ist der Corona-Impfstoff von AstraZeneca nicht mehr zugelassen – das habe „kommerzielle Gründe“, sagt das schwedisch-britische…

Zulassung für Astrazeneca-Impfstoff zurückgezogen - 'kommerzielle Gründe'

BRÜSSEL/HAMBURG (dpa-AFX) - Der Corona-Impfstoff des schwedisch-britischen Pharmaunternehmens Astrazeneca , Vaxzevria, ist nicht mehr in der…

Warum der Impfstoff Vaxzevria in der EU nicht mehr zugelassen ist

Seit heute ist der Corona-Impfstoff von AstraZeneca in der EU nicht mehr zugelassen. In den sozialen Medien werden Bedenken bei…

Amgen, newer rivals could threaten Novo Nordisk and Eli Lillys weight loss drug dominance

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.…

AstraZeneca concludes equity investment in Cellectis

AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.…

AstraZeneca completes Cellectis equity investment

7 May 2024 AstraZeneca completes equity investment agreement with Cellectis AstraZeneca today announced the successful completion of an equity investment with Cellectis,…

The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes

AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.…

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant

…

dpa-AFX ProFeed